# Study of EBI-005 in Dry Eye Disease (DED)

> **NCT02405039** · PHASE3 · UNKNOWN · sponsor: **Eleven Biotherapeutics** · enrollment: 188 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** EBI-005
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02405039
- **Lead sponsor:** Eleven Biotherapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2016-06
- **Final completion:** 2016-07
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2015-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02405039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02405039, "Study of EBI-005 in Dry Eye Disease (DED)". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT02405039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*